866-997-4948(US-Canada Toll Free)

Global Prescription Drugs Market Insights, Forecast to 2025

Published By :

QYResearch

Published Date : Sep 2018

Category :

Pharmaceutical

No. of Pages : 126 Pages

This report studies the global market size of Prescription Drugs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Prescription Drugs in these regions.
This research report categorizes the global Prescription Drugs market by players/brands, region, type and application. This report also studies the global market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels, distributors and Porter's Five Forces Analysis.

Amedication(also referred to asmedicine,pharmaceutical drug, or simplydrug) is adrugused todiagnose,cure,treat, orpreventdisease.Drug therapy (pharmacotherapy) is an important part of themedical fieldand relies on the science ofpharmacologyfor continual advancement and onpharmacyfor appropriate management.
In 2017, the global Prescription Drugs market size was xx million US$ and is forecast to xx million US in 2025, growing at a CAGR of xx% from 2018. The objectives of this study are to define, segment, and project the size of the Prescription Drugs market based on company, product type, application and key regions.

The various contributors involved in the value chain of Prescription Drugs include manufacturers, suppliers, distributors, intermediaries, and customers. The key manufacturers in the Prescription Drugs include
Pfizer
Roche
Sanofi
Johnson & Johnson
Merck & Co. (MSD)
Novartis
AbbVie
Gilead Sciences
GlaxoSmithKline (GSK)
Amgen
AstraZeneca
Bristol-Myers Squibb
Eli Lilly
Teva
Bayer
Novo Nordisk
Allergan
Shire
Boehringer Ingelheim
Takeda

Market Size Split by Type
Brand Drugs
Generic Drug
Market Size Split by Application
Hospital
Clinic
Other

Market size split by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Prescription Drugs market size (value & volume) by company, key regions/countries, products and application, history data from 2013 to 2017, and forecast to 2025.
To understand the structure of Prescription Drugs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Prescription Drugs manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, SWOT analysis and development plans in next few years.
To analyze the Prescription Drugs with respect to individual growth trends, future prospects, and their contribution to the total market.
To project the value and volume of Prescription Drugs submarkets, with respect to key regions (along with their respective key countries).
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
To strategically profile the key players and comprehensively analyze their growth strategies.

In this study, the years considered to estimate the market size of Prescription Drugs are as follows:
History Year: 2013-2017
Base Year: 2017
Estimated Year: 2018
Forecast Year 2018 to 2025

This report includes the estimation of market size for value (million US$) and volume (K Units). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Prescription Drugs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2017 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.
Table of Contents

1 Study Coverage
1.1 Prescription Drugs Product
1.2 Key Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Prescription Drugs Market Size Growth Rate by Type
1.4.2 Brand Drugs
1.4.3 Generic Drug
1.5 Market by Application
1.5.1 Global Prescription Drugs Market Size Growth Rate by Application
1.5.2 Hospital
1.5.3 Clinic
1.5.4 Other
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Prescription Drugs Market Size
2.1.1 Global Prescription Drugs Revenue 2016-2025
2.1.2 Global Prescription Drugs Sales 2016-2025
2.2 Prescription Drugs Growth Rate by Regions
2.2.1 Global Prescription Drugs Sales by Regions
2.2.2 Global Prescription Drugs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Prescription Drugs Sales by Manufacturers
3.1.1 Prescription Drugs Sales by Manufacturers
3.1.2 Prescription Drugs Sales Market Share by Manufacturers
3.1.3 Global Prescription Drugs Market Concentration Ratio (CR5 and HHI)
3.2 Prescription Drugs Revenue by Manufacturers
3.2.1 Prescription Drugs Revenue by Manufacturers (2016-2018)
3.2.2 Prescription Drugs Revenue Share by Manufacturers (2016-2018)
3.3 Prescription Drugs Price by Manufacturers
3.4 Prescription Drugs Manufacturing Base Distribution, Product Types
3.4.1 Prescription Drugs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Prescription Drugs Product Category
3.4.3 Date of International Manufacturers Enter into Prescription Drugs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type
4.1 Global Prescription Drugs Sales by Type
4.2 Global Prescription Drugs Revenue by Type
4.3 Prescription Drugs Price by Type

5 Breakdown Data by Application
5.1 Overview
5.2 Global Prescription Drugs Breakdown Data by Application

6 North America
6.1 North America Prescription Drugs by Countries
6.1.1 North America Prescription Drugs Sales by Countries
6.1.2 North America Prescription Drugs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Prescription Drugs by Type
6.3 North America Prescription Drugs by Application
6.4 North America Prescription Drugs by Company

7 Europe
7.1 Europe Prescription Drugs by Countries
7.1.1 Europe Prescription Drugs Sales by Countries
7.1.2 Europe Prescription Drugs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Prescription Drugs by Type
7.3 Europe Prescription Drugs by Application
7.4 Europe Prescription Drugs by Company

8 Asia Pacific
8.1 Asia Pacific Prescription Drugs by Countries
8.1.1 Asia Pacific Prescription Drugs Sales by Countries
8.1.2 Asia Pacific Prescription Drugs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Prescription Drugs by Type
8.3 Asia Pacific Prescription Drugs by Application
8.4 Asia Pacific Prescription Drugs by Company

9 Central & South America
9.1 Central & South America Prescription Drugs by Countries
9.1.1 Central & South America Prescription Drugs Sales by Countries
9.1.2 Central & South America Prescription Drugs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Prescription Drugs by Type
9.3 Central & South America Prescription Drugs by Application
9.4 Central & South America Prescription Drugs by Company

10 Middle East and Africa
10.1 Middle East and Africa Prescription Drugs by Countries
10.1.1 Middle East and Africa Prescription Drugs Sales by Countries
10.1.2 Middle East and Africa Prescription Drugs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Prescription Drugs by Type
10.3 Middle East and Africa Prescription Drugs by Application
10.4 Middle East and Africa Prescription Drugs by Company

11 Company Profiles
11.1 Pfizer
11.1.1 Pfizer Company Details
11.1.2 Company Description
11.1.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.1.4 Prescription Drugs Product Description
11.1.5 Recent Development
11.2 Roche
11.2.1 Roche Company Details
11.2.2 Company Description
11.2.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.2.4 Prescription Drugs Product Description
11.2.5 Recent Development
11.3 Sanofi
11.3.1 Sanofi Company Details
11.3.2 Company Description
11.3.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.3.4 Prescription Drugs Product Description
11.3.5 Recent Development
11.4 Johnson & Johnson
11.4.1 Johnson & Johnson Company Details
11.4.2 Company Description
11.4.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.4.4 Prescription Drugs Product Description
11.4.5 Recent Development
11.5 Merck & Co. (MSD)
11.5.1 Merck & Co. (MSD) Company Details
11.5.2 Company Description
11.5.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.5.4 Prescription Drugs Product Description
11.5.5 Recent Development
11.6 Novartis
11.6.1 Novartis Company Details
11.6.2 Company Description
11.6.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.6.4 Prescription Drugs Product Description
11.6.5 Recent Development
11.7 AbbVie
11.7.1 AbbVie Company Details
11.7.2 Company Description
11.7.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.7.4 Prescription Drugs Product Description
11.7.5 Recent Development
11.8 Gilead Sciences
11.8.1 Gilead Sciences Company Details
11.8.2 Company Description
11.8.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.8.4 Prescription Drugs Product Description
11.8.5 Recent Development
11.9 GlaxoSmithKline (GSK)
11.9.1 GlaxoSmithKline (GSK) Company Details
11.9.2 Company Description
11.9.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.9.4 Prescription Drugs Product Description
11.9.5 Recent Development
11.10 Amgen
11.10.1 Amgen Company Details
11.10.2 Company Description
11.10.3 Sales, Revenue and Gross Margin of Prescription Drugs
11.10.4 Prescription Drugs Product Description
11.10.5 Recent Development
11.11 AstraZeneca
11.12 Bristol-Myers Squibb
11.13 Eli Lilly
11.14 Teva
11.15 Bayer
11.16 Novo Nordisk
11.17 Allergan
11.18 Shire
11.19 Boehringer Ingelheim
11.20 Takeda

12 Market Opportunities, Challenges, Risks and Influences Factors Analysis
12.1 Market Opportunities and Drivers
12.2 Market Challenges
12.3 Market Risks/Restraints
12.4 Key World Economic Indicators

13 Value Chain and Sales Channels Analysis
13.1 Value Chain Analysis
13.1.1 Typical Suppliers of Key Prescription Drugs Raw Material
13.1.2 Prescription Drugs Customers
13.2 Sales Channels Analysis
13.2.1 Sales Channels Analysis
13.2.2 Distributors

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
15.3 Disclaimer

List of Table

List of Tables and Figures

Figure Picture of Prescription Drugs
Figure Global Prescription Drugs Production (K Units) and CAGR (%) Comparison by Types (Product Category) (2013-2025)
Figure Global Prescription Drugs Production Market Share by Types (Product Category) in 2017
Figure Brand Drugs Product Picture
Table Major Manufacturers of Brand Drugs
Figure Generic Drug Product Picture
Table Major Manufacturers of Generic Drug
Table Global Prescription Drugs Market Size Growth Rate by Application 2018-2025 (K Units)
Figure Hospital
Figure Clinic
Figure Other
Figure Prescription Drugs Report Years Considered
Figure Global Prescription Drugs Market Size 2016-2025 (Million US$)
Figure Global Prescription Drugs Sales 2016-2025 (K Units)
Table Global Prescription Drugs Market Size by Regions 2016-2025 (K Units) & (Million US$)
Table Global Prescription Drugs Sales by Regions 2016-2025 (K Units)
Table Global Prescription Drugs Sales Market Share by Regions 2016-2025
Figure Global Prescription Drugs Sales Market Share by Regions 2016-2025
Figure 2017 Global Prescription Drugs Sales Market Share by Regions
Table Global Prescription Drugs Revenue by Regions 2016-2025 (Million US$)
Table Global Prescription Drugs Revenue Market Share by Regions 2016-2025
Figure Global Prescription Drugs Revenue Market Share by Regions 2016-2025
Figure 2017 Global Prescription Drugs Revenue Market Share by Regions
Table Global Prescription Drugs Sales by Manufacturers (2016-2018) (K Units)
Table Global Prescription Drugs Sales Share by Manufacturers (2016-2018)
Figure Global Prescription Drugs Sales Share by Manufacturers in 2017
Table Prescription Drugs Revenue by Manufacturers (2016-2018) (Million US$)
Table Prescription Drugs Revenue Share by Manufacturers (2016-2018)
Figure Prescription Drugs Value Share by Manufacturers in 2017
Table Global Prescription Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Key Manufacturers Prescription Drugs Price (2016-2018) (USD/Unit)
Table Prescription Drugs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Prescription Drugs Product Category
Table Date of International Manufacturers Enter into Prescription Drugs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Prescription Drugs Sales by Type (2016-2025) (K Units)
Table Global Prescription Drugs Sales Share by Type (2016-2025)
Figure Global Prescription Drugs Sales Market Share by Type (2016-2025)
Figure Global Prescription Drugs Sales Market Share by Type in 2017
Table Global Prescription Drugs Revenue by Type (2016-2025) (Million US$)
Table Global Prescription Drugs Revenue Share by Type (2016-2025)
Figure Global Prescription Drugs Revenue Market Share by Type (2016-2025)
Figure Global Prescription Drugs Revenue Market Share by Type in 2017
Table Prescription Drugs Price by Type 2013-2018 (USD/Unit)
Table Global Prescription Drugs Sales by Application (2016-2025) (K Units)
Table Global Prescription Drugs Sales Share by Application (2016-2025)
Figure Global Sales Prescription Drugs Market Share by Application (2016-2025)
Figure Global Sales Prescription Drugs Market Share by Application (2016-2025)
Figure North America Prescription Drugs Sales Growth Rate 2016-2025 (K Units)
Figure North America Prescription Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table North America Prescription Drugs Sales by Countries (2016-2025) (K Units)
Table North America Prescription Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 North America Prescription Drugs Sales Market Share by Countries
Table North America Prescription Drugs Revenue by Countries (2016-2025) (Million US$)
Table North America Prescription Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 North America Prescription Drugs Revenue Market Share by Countries
Figure United States Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure United States Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Canada Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Canada Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Mexico Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Mexico Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table North America Prescription Drugs Sales by Type (2016-2025) (K Units)
Table North America Prescription Drugs Sales Market Share by Type (2016-2025)
Figure 2017 North America Prescription Drugs Market Share by Type
Table North America Prescription Drugs Sales by Application (2016-2025) (K Units)
Table North America Prescription Drugs Sales Market Share by Application (2016-2025)
Figure 2017 North America Prescription Drugs Market Share by Application
Table North America Prescription Drugs Sales by Company (2016-2018) (K Units)
Table North America Prescription Drugs Sales Market Share by Company (2016-2018)
Figure North America Prescription Drugs Sales Market Share by Company in 2017
Figure Europe Prescription Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Europe Prescription Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Europe Prescription Drugs Sales by Countries (2016-2025) (K Units)
Table Europe Prescription Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Europe Prescription Drugs Sales Market Share by Countries
Table Europe Prescription Drugs Revenue by Countries (2016-2025) (Million US$)
Table Europe Prescription Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Europe Prescription Drugs Revenue Market Share by Countries
Figure Germany Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Germany Prescription Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure France Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure France Prescription Drugs Revenue Growth Rate (2016-2025) (K Units)
Figure UK Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure UK Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Italy Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Italy Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Russia Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Russia Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Europe Prescription Drugs Sales by Type (2016-2025) (K Units)
Table Europe Prescription Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Europe Prescription Drugs Market Share by Type
Table Europe Prescription Drugs Sales by Application (2016-2025) (K Units)
Table Europe Prescription Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Europe Prescription Drugs Market Share by Application
Table Europe Prescription Drugs Sales by Company (2016-2018) (K Units)
Table Europe Prescription Drugs Sales Market Share by Company (2016-2018)
Figure Europe Prescription Drugs Sales Market Share by Company in 2017
Figure Asia Pacific Prescription Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Asia Pacific Prescription Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Asia Pacific Prescription Drugs Sales by Countries (2016-2025) (K Units)
Table Asia Pacific Prescription Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Prescription Drugs Sales Market Share by Countries
Table Asia Pacific Prescription Drugs Revenue by Countries (2016-2025) (Million US$)
Table Asia Pacific Prescription Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Asia Pacific Prescription Drugs Revenue Market Share by Countries
Figure China Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure China Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Japan Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Japan Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Korea Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Korea Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure India Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure India Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Australia Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Australia Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Indonesia Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Indonesia Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Malaysia Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Malaysia Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Philippines Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Philippines Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Thailand Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Thailand Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Vietnam Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Vietnam Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Singapore Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Singapore Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Asia Pacific Prescription Drugs Sales by Type (2016-2025) (K Units)
Table Asia Pacific Prescription Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Asia Pacific Prescription Drugs Market Share by Type
Table Asia Pacific Prescription Drugs Sales by Application (2016-2025) (K Units)
Table Asia Pacific Prescription Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Asia Pacific Prescription Drugs Market Share by Application
Table Asia Pacific Prescription Drugs Sales by Company (2016-2018) (K Units)
Table Asia Pacific Prescription Drugs Sales Market Share by Company (2016-2018)
Figure Asia Pacific Prescription Drugs Sales Market Share by Company in 2017
Figure Central & South America Prescription Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Central & South America Prescription Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Central & South America Prescription Drugs Sales by Countries (2016-2025) (K Units)
Table Central & South America Prescription Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Central & South America Prescription Drugs Sales Market Share by Countries
Table Central & South America Prescription Drugs Revenue by Countries (2016-2025) (Million US$)
Table Central & South America Prescription Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Central & South America Prescription Drugs Revenue Market Share by Countries
Figure Brazil Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Brazil Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Argentina Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Argentina Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Central & South America Prescription Drugs Sales by Type (2016-2025) (K Units)
Table Central & South America Prescription Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Central & South America Prescription Drugs Market Share by Type
Table Central & South America Prescription Drugs Sales by Application (2016-2025) (K Units)
Table Central & South America Prescription Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Central & South America Prescription Drugs Market Share by Application
Table Central & South America Prescription Drugs Sales by Company (2016-2018) (K Units)
Table Central & South America Prescription Drugs Sales Market Share by Company (2016-2018)
Figure Central & South America Prescription Drugs Sales Market Share by Company in 2017
Figure Middle East and Africa Prescription Drugs Sales Growth Rate 2016-2025 (K Units)
Figure Middle East and Africa Prescription Drugs Revenue Growth Rate 2016-2025 (Million US$)
Table Middle East and Africa Prescription Drugs Sales by Countries (2016-2025) (K Units)
Table Middle East and Africa Prescription Drugs Sales Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Prescription Drugs Sales Market Share by Countries
Table Middle East and Africa Prescription Drugs Revenue by Countries (2016-2025) (Million US$)
Table Middle East and Africa Prescription Drugs Revenue Market Share by Countries (2016-2025)
Figure 2017 Middle East and Africa Prescription Drugs Revenue Market Share by Countries
Figure GCC Countries Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure GCC Countries Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Turkey Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Turkey Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure Egypt Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure Egypt Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Figure South Africa Prescription Drugs Sales Growth Rate (2016-2025) (K Units)
Figure South Africa Prescription Drugs Revenue Growth Rate (2016-2025) (Million US$)
Table Middle East and Africa Prescription Drugs Sales by Type (2016-2025) (K Units)
Table Middle East and Africa Prescription Drugs Sales Market Share by Type (2016-2025)
Figure 2017 Middle East and Africa Prescription Drugs Market Share by Type
Table Middle East and Africa Prescription Drugs Sales by Application (2016-2025) (K Units)
Table Middle East and Africa Prescription Drugs Sales Market Share by Application (2016-2025)
Figure 2017 Middle East and Africa Prescription Drugs Market Share by Application
Table Middle East and Africa Prescription Drugs Sales by Company (2016-2018) (K Units)
Table Middle East and Africa Prescription Drugs Sales Market Share by Company (2016-2018)
Figure Middle East and Africa Prescription Drugs Sales Market Share by Company in 2017
Table Pfizer Company Details
Table Pfizer Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Pfizer Recent Development
Table Roche Company Details
Table Roche Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Roche Recent Development
Table Sanofi Company Details
Table Sanofi Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Sanofi Recent Development
Table Johnson & Johnson Company Details
Table Johnson & Johnson Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Johnson & Johnson Recent Development
Table Merck & Co. (MSD) Company Details
Table Merck & Co. (MSD) Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Merck & Co. (MSD) Recent Development
Table Novartis Company Details
Table Novartis Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Novartis Recent Development
Table AbbVie Company Details
Table AbbVie Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table AbbVie Recent Development
Table Gilead Sciences Company Details
Table Gilead Sciences Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Gilead Sciences Recent Development
Table GlaxoSmithKline (GSK) Company Details
Table GlaxoSmithKline (GSK) Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table GlaxoSmithKline (GSK) Recent Development
Table Amgen Company Details
Table Amgen Prescription Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2016-2018)
Table Amgen Recent Development
Table AstraZeneca Company Details
Table Bristol-Myers Squibb Company Details
Table Eli Lilly Company Details
Table Teva Company Details
Table Bayer Company Details
Table Novo Nordisk Company Details
Table Allergan Company Details
Table Shire Company Details
Table Boehringer Ingelheim Company Details
Table Takeda Company Details
Figure GDP by Regions / Largest Economies Pie Chart in 2016
Figure G20 GDP Long-Term Forecast Total, Million US dollars, 2060
Figure G20 Gross Domestic Product (GDP)Total, US Dollars/Capita, 2016
Figure Saving Rate Total, % of GDP, 2015
Table Prescription Drugs Value Chain
Table Typical Suppliers of Key Prescription Drugs Raw Material
Table Prescription Drugs Customers List
Table Prescription Drugs Sales Channels
Table Prescription Drugs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title
  • Company
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *